CN102876606A - 一种高产肽聚糖的工程菌及其应用 - Google Patents
一种高产肽聚糖的工程菌及其应用 Download PDFInfo
- Publication number
- CN102876606A CN102876606A CN2012103595626A CN201210359562A CN102876606A CN 102876606 A CN102876606 A CN 102876606A CN 2012103595626 A CN2012103595626 A CN 2012103595626A CN 201210359562 A CN201210359562 A CN 201210359562A CN 102876606 A CN102876606 A CN 102876606A
- Authority
- CN
- China
- Prior art keywords
- peptidoglycan
- thalline
- strain
- hzsb
- engineering bacteria
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 title claims abstract description 36
- 108010013639 Peptidoglycan Proteins 0.000 title claims abstract description 36
- 241000894006 Bacteria Species 0.000 title claims abstract description 26
- 238000000855 fermentation Methods 0.000 claims abstract description 20
- 230000004151 fermentation Effects 0.000 claims abstract description 19
- 240000001046 Lactobacillus acidophilus Species 0.000 claims abstract description 9
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims abstract description 9
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims abstract description 9
- 238000004519 manufacturing process Methods 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims description 23
- 239000007788 liquid Substances 0.000 claims description 20
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 claims description 19
- 238000001556 precipitation Methods 0.000 claims description 18
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 15
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Natural products OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 15
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 13
- 239000008103 glucose Substances 0.000 claims description 13
- 239000000843 powder Substances 0.000 claims description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- 239000001888 Peptone Substances 0.000 claims description 12
- 108010080698 Peptones Proteins 0.000 claims description 12
- 235000019319 peptone Nutrition 0.000 claims description 12
- 239000000243 solution Substances 0.000 claims description 12
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 10
- 239000008101 lactose Substances 0.000 claims description 10
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 9
- 239000001632 sodium acetate Substances 0.000 claims description 9
- 235000017281 sodium acetate Nutrition 0.000 claims description 9
- 235000015193 tomato juice Nutrition 0.000 claims description 9
- 239000002253 acid Substances 0.000 claims description 8
- 235000013405 beer Nutrition 0.000 claims description 7
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 7
- 229920000053 polysorbate 80 Polymers 0.000 claims description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 6
- 230000004913 activation Effects 0.000 claims description 6
- -1 citric acid diamines Chemical class 0.000 claims description 6
- 238000005238 degreasing Methods 0.000 claims description 6
- 230000001413 cellular effect Effects 0.000 claims description 5
- 108091005804 Peptidases Proteins 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- 239000006166 lysate Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 108010019160 Pancreatin Proteins 0.000 claims description 3
- 239000004365 Protease Substances 0.000 claims description 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 3
- 238000005336 cracking Methods 0.000 claims description 3
- 229940055695 pancreatin Drugs 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 3
- 238000013467 fragmentation Methods 0.000 claims description 2
- 238000006062 fragmentation reaction Methods 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 239000011259 mixed solution Substances 0.000 claims description 2
- 102000035195 Peptidases Human genes 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 238000009395 breeding Methods 0.000 abstract description 3
- 230000001488 breeding effect Effects 0.000 abstract description 3
- 239000001963 growth medium Substances 0.000 abstract description 3
- 230000035772 mutation Effects 0.000 abstract description 3
- 108090000623 proteins and genes Proteins 0.000 abstract description 3
- 230000006798 recombination Effects 0.000 abstract description 2
- 238000005215 recombination Methods 0.000 abstract description 2
- 241001052560 Thallis Species 0.000 abstract 2
- 230000001580 bacterial effect Effects 0.000 description 26
- 239000002609 medium Substances 0.000 description 26
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 11
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 10
- 238000012216 screening Methods 0.000 description 10
- 235000015097 nutrients Nutrition 0.000 description 8
- 238000005406 washing Methods 0.000 description 8
- 244000005700 microbiome Species 0.000 description 7
- 238000005457 optimization Methods 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 239000000819 hypertonic solution Substances 0.000 description 6
- 229940021223 hypertonic solution Drugs 0.000 description 6
- 239000002054 inoculum Substances 0.000 description 6
- 231100000350 mutagenesis Toxicity 0.000 description 6
- 238000002703 mutagenesis Methods 0.000 description 6
- 239000002504 physiological saline solution Substances 0.000 description 6
- 230000001954 sterilising effect Effects 0.000 description 6
- 238000004659 sterilization and disinfection Methods 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 241000193830 Bacillus <bacterium> Species 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- KIWBPDUYBMNFTB-UHFFFAOYSA-N Ethyl hydrogen sulfate Chemical compound CCOS(O)(=O)=O KIWBPDUYBMNFTB-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- DQJCDTNMLBYVAY-ZXXIYAEKSA-N (2S,5R,10R,13R)-16-{[(2R,3S,4R,5R)-3-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid Chemical compound NCCCC[C@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@@H](C)NC(=O)C(C)O[C@@H]1[C@@H](NCC)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O1 DQJCDTNMLBYVAY-ZXXIYAEKSA-N 0.000 description 2
- 201000004384 Alopecia Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 108010015899 Glycopeptides Proteins 0.000 description 2
- 102000002068 Glycopeptides Human genes 0.000 description 2
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 description 2
- 108010064696 N,O-diacetylmuramidase Proteins 0.000 description 2
- 102100040247 Tumor necrosis factor Human genes 0.000 description 2
- CKUAXEQHGKSLHN-UHFFFAOYSA-N [C].[N] Chemical compound [C].[N] CKUAXEQHGKSLHN-UHFFFAOYSA-N 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000002826 coolant Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical compound CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 229960001438 immunostimulant agent Drugs 0.000 description 2
- 239000003022 immunostimulating agent Substances 0.000 description 2
- 230000003308 immunostimulating effect Effects 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 210000003024 peritoneal macrophage Anatomy 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000008521 reorganization Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 108010046845 tryptones Proteins 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000726221 Gemma Species 0.000 description 1
- 238000003794 Gram staining Methods 0.000 description 1
- 206010021703 Indifference Diseases 0.000 description 1
- 102100037850 Interferon gamma Human genes 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000000184 desmutagenic effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012092 media component Substances 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 125000000018 nitroso group Chemical group N(=O)* 0.000 description 1
- 230000003534 oscillatory effect Effects 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 235000019991 rice wine Nutrition 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- PODWXQQNRWNDGD-UHFFFAOYSA-L sodium thiosulfate pentahydrate Chemical compound O.O.O.O.O.[Na+].[Na+].[O-]S([S-])(=O)=O PODWXQQNRWNDGD-UHFFFAOYSA-L 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
初始pH值 | 活菌数(109cfu/mL) |
5.6 | 4.52 |
5.8 | 5.76 |
6.0 | 6.83 |
6.2 | 7.98 |
6.4 | 8.17 |
6.6 | 8.02 |
6.8 | 6.86 |
7.0 | 4.65 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210359562 CN102876606B (zh) | 2012-09-25 | 2012-09-25 | 一种高产肽聚糖的工程菌及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210359562 CN102876606B (zh) | 2012-09-25 | 2012-09-25 | 一种高产肽聚糖的工程菌及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102876606A true CN102876606A (zh) | 2013-01-16 |
CN102876606B CN102876606B (zh) | 2013-07-10 |
Family
ID=47478128
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201210359562 Expired - Fee Related CN102876606B (zh) | 2012-09-25 | 2012-09-25 | 一种高产肽聚糖的工程菌及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102876606B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103396496A (zh) * | 2013-07-16 | 2013-11-20 | 宁波大学 | 一种改性嗜酸乳杆菌肽聚糖的制备方法 |
CN106912602A (zh) * | 2017-01-24 | 2017-07-04 | 深圳市大百汇技术有限公司 | 一种多汁乳菇多糖的嗜酸乳杆菌发酵乳及其制备方法 |
WO2020006663A1 (zh) * | 2018-07-02 | 2020-01-09 | 葡萄王生技股份有限公司 | 用于改善代谢症候群的新颖副干酪乳杆菌 gks6、其培养基、培养方法、用途、医药组合物及可食用组合物 |
-
2012
- 2012-09-25 CN CN 201210359562 patent/CN102876606B/zh not_active Expired - Fee Related
Non-Patent Citations (3)
Title |
---|
ANA M.P.GOMES ET AL: "Bifidobacterium spp. and Lactobacillus acidophilus:biological,biochemical,technological and therapeutical properties relevant for use as probiotics", 《TRENDS IN FOODS SCIENCE & TECHNOLOGY》 * |
乐军等: "双歧杆菌双歧杆菌细胞壁完整肽聚糖的分离纯化", 《中国微生态学杂志》 * |
马西艺等: "乳酸杆菌肽聚糖的分离鉴定及其免疫活性", 《无锡轻工大学学报》 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103396496A (zh) * | 2013-07-16 | 2013-11-20 | 宁波大学 | 一种改性嗜酸乳杆菌肽聚糖的制备方法 |
CN103396496B (zh) * | 2013-07-16 | 2015-07-08 | 宁波大学 | 一种改性嗜酸乳杆菌肽聚糖的制备方法 |
CN106912602A (zh) * | 2017-01-24 | 2017-07-04 | 深圳市大百汇技术有限公司 | 一种多汁乳菇多糖的嗜酸乳杆菌发酵乳及其制备方法 |
CN106912602B (zh) * | 2017-01-24 | 2020-10-02 | 深圳市大百汇技术有限公司 | 一种多汁乳菇多糖的嗜酸乳杆菌发酵乳及其制备方法 |
WO2020006663A1 (zh) * | 2018-07-02 | 2020-01-09 | 葡萄王生技股份有限公司 | 用于改善代谢症候群的新颖副干酪乳杆菌 gks6、其培养基、培养方法、用途、医药组合物及可食用组合物 |
Also Published As
Publication number | Publication date |
---|---|
CN102876606B (zh) | 2013-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101555461B (zh) | 一株产碱性纤维素酶菌株lt3及其选育方法和产酶条件初步优化 | |
CN102220269B (zh) | 一种丁酸梭菌及丁酸梭菌饲料添加剂的生产方法 | |
WO2021196693A1 (zh) | 一种草酸青霉菌sdf-25及其应用 | |
CN106434417A (zh) | 一株耐高温产纤维素酶菌及其应用 | |
CN113061555B (zh) | 一株产纤维素酶的芽孢杆菌菌株筛选及其应用 | |
CN109536409B (zh) | 一种抗逆性高且可利用多种碳源的乳酸片球菌菌株及利用该菌株生产乳酸的方法 | |
CN102703339B (zh) | 高产精氨酸脱亚胺酶菌株及用它生产l-瓜氨酸的方法 | |
CN102851239A (zh) | 一株壳聚糖酶生产菌株及应用该菌株生产壳寡糖的方法 | |
CN108342342A (zh) | 一种富含铜的枯草芽孢杆菌及其培养方法 | |
CN110373359A (zh) | 一种白色链霉菌X-18及利用该菌生产ε-聚赖氨酸的方法 | |
CN102876606B (zh) | 一种高产肽聚糖的工程菌及其应用 | |
CN102634464A (zh) | 耐高温酿酒酵母及其分离培养方法 | |
CN102972211A (zh) | 一种提高灵芝菌丝生长速度和液体发酵生物量的方法 | |
CN113980848A (zh) | 一种戊糖片球菌sbc5及其应用 | |
CN102634460B (zh) | 米根霉rh1-5及其分离培养方法 | |
CN114350555B (zh) | 副干酪乳杆菌Lp.R3及其在制备提高免疫力药物中的应用 | |
CN114107089B (zh) | 一株植物乳杆菌及其发酵提取β-葡聚糖的方法及应用 | |
CN105420160B (zh) | 一种热凝胶多糖产生菌株及其应用 | |
CN108865927B (zh) | 低温酵解玉米秸秆的细菌菌株及其发酵培养方法和应用 | |
CN102533570B (zh) | 一种黑曲霉及其应用及发酵制备柠檬酸的方法 | |
TW201420760A (zh) | 枯草桿菌菌株Bacillus subtilis及其應用 | |
CN101092601A (zh) | 低能离子诱变灰色变异链霉菌选育万隆霉素高产菌株的方法 | |
CN116549507A (zh) | 一种微生物发酵法制备葛根提取物的方法 | |
CN100420735C (zh) | 臭曲霉菌株及其用途 | |
CN108841743A (zh) | 寒地秸秆腐熟细菌菌株及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: ZHEJIANG CROWN TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: HANGZHOU SHIBO BIOTECHNOLOGY DEVELOPMENT INSTITUTE CO., LTD. Effective date: 20140326 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Hu Weiqing Inventor after: Ye Mao Inventor after: Hu Xiangdong Inventor after: Zhu Jing Inventor after: Xu Meifang Inventor before: Hu Xiangdong Inventor before: Ye Mao Inventor before: Hu Weiqing Inventor before: Zhu Jing Inventor before: Xu Meifang |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: HU XIANGDONG YE MAO HU WEIQING ZHU JING XU MEIFANG TO: HU WEIQING YE MAO HU XIANGDONG ZHU JING XU MEIFANG |
|
TR01 | Transfer of patent right |
Effective date of registration: 20140326 Address after: 310012, room 40, No. 203 Huang Shan Road, Hangzhou, Zhejiang Patentee after: ZHEJIANG CROWN TECHNOLOGY Co.,Ltd. Address before: 310012, room 40, No. 205 Huang Shan Road, Xihu District, Zhejiang, Hangzhou Patentee before: HANGZHOU SHIBO BIOTECHNOLOGY DEVELOPMENT INSTITUTE Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130710 |
|
CF01 | Termination of patent right due to non-payment of annual fee |